Leiomyosarkoma Doctors Abroad — Page 2

Professor Tahsin Ozadli is a specialist medical oncologist at Valued Med Hub Hospitals who focuses on managing complex soft tissue tumours.

• Trained at the Ankara Oncology Training and Research Hospital
• Focuses on gastrointestinal and oesophageal cancer care
• Manages systemic treatments for rare muscle-tissue tumours
• Published researcher in oncological outcomes and patient care
• Registered member of the Turkish Medical Oncology Society

Professor Ozcan Yildiz is a senior medical oncologist at Medipol Mega University Hospital with a decade of documented success in managing complex neuroendocrine tumours.

• Specialises in systemic therapy for rare soft tissue sarcomas and gastroenteropancreatic tumours
• Maintains an active research profile with over 15 publications in international peer-reviewed medical journals
• Experienced in managing paraneoplastic syndromes – secondary conditions caused by a patient's immune response to cancer
• Focuses on multidisciplinary care for metastatic cases to improve survival and quality of life

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Associate Professor Nail Paksoy is a highly regarded medical oncologist specialising in complex sarcomas at Medipol Bahçelievler University Hospital.

• Holds European Society for Medical Oncology (ESMO) Board Certification, a mark of top-tier professional standards
• Specialises in managing leiomyosarcoma and other soft tissue sarcomas using the latest systemic therapy protocols
• Expert in salvage therapy for pretreated metastatic sarcoma cases to improve patient outcomes
• Served as a subinvestigator in multiple international clinical trials for targeted cancer therapies
• Extensively published in medical journals on sarcoma treatments and chemotherapy desensitisation protocols

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.